Hope with Hydrea Battling Resistant Chronic Myeloid Leukemia

Category: Health

Chronic Myeloid Leukemia (CML) is a type of blood cancer that affects the white blood cells. In most cases, it develops slowly over time. Some patients respond well to standard treatments, especially targeted drugs called tyrosine kinase inhibitors (TKIs). But for a few people, the disease becomes resistant, meaning the regular treatments stop working. In these tough times, a medicine called Hydrea (also known by its generic name Hydroxyurea) brings hope and relief.